SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Omeros -- Ignore unavailable to you. Want to Upgrade?


To: rkrw who wrote (425)7/6/2017 4:07:14 PM
From: ghmm  Read Replies (1) | Respond to of 464
 
I thought it was originally 3 parts now up to 6. I guess he'll look for a publisher soon.



To: rkrw who wrote (425)7/6/2017 4:07:17 PM
From: BulbaMan  Respond to of 464
 
Bullish Oneil Trader Omeros article on Seeking Alpha posted today. It mentions ChemoCentryx competition but concludes OMS721 is better drug.
seekingalpha.com
Peace & good health,
Bulba